Plasma exchange therapy is effective for severe relapses in MS patients who respond inadequately to standard corticosteroids, ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Anti-CD20 therapies like Ocrevus and rituximab may be ineffective at slowing disability progression in PPMS patients, per a ...

Cionic is partnering with a veteran-owned business to improve access to its Neural Sleeve for improving patients' walking ...

I drive a wheelchair now. Mine tilts and reclines, so it’s a bit heavier than most. It’s not a car, but there’s a certain amount of responsibility that goes with it because like any vehicle, it too is ...

In the world of chronic illness, people tend to be perceived differently depending on the visibility of their condition. Some illnesses are easily noticeable while others aren’t, but both pose ...

Well, it’s that time of the year again: flu season. I guess you could say it’s COVID-19 season, too, though confirmed and probable cases of COVID-19 started increasing in late June here in ...

The MS Society of Canada is hosting its annual MS Read-a-Thon, a fundraiser where children are encouraged to read for a month to support people with multiple sclerosis (MS) in their community.